Verastem, Inc.

Verastem, Inc.verified

2VSA.F

Price:

$8.95

Market Cap:

$627.18M

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter, parallel cohort, randomized open label trial to evaluate the efficacy and safety of avutometinib and in combination with defactinib, an oral small molecule inhibitor of focal adhesion kinase (FAK) in patients with recurrent low grade serous ovarian cancer; and RAMP 202...[Read more]

Industry

Biotechnology

IPO Date

2012-02-13

Stock Exchange

FSX

Ticker

2VSA.F

The ROE as of December 2025 (TTM) for Verastem, Inc. (2VSA.F) is -9587.28%

According to Verastem, Inc.’s latest financial reports and current stock price. The company's current ROE is -9587.28%. This represents a change of -16230.20% compared to the average of 59.44% of the last 4 quarters.

Verastem, Inc. (2VSA.F) Historical ROE (quarterly & annually)

How has 2VSA.F ROE performed in the past?

The mean historical ROE of Verastem, Inc. over the last ten years is -235.86%. The current -9587.28% ROE has changed 3.96% with respect to the historical average. Over the past ten years (40 quarters), 2VSA.F's ROE was at its highest in in the December 2024 quarter at 223.41%. The ROE was at its lowest in in the December 2019 quarter at -540.48%.

Quarterly (TTM)
Annual

Average

-235.86%

Median

-70.03%

Minimum

-2079.86%

Maximum

452.14%

Verastem, Inc. (2VSA.F) ROE by Quarter and Year

Discovering the peaks and valleys of Verastem, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.47%

Maximum Annual ROE = 452.14%

Minimum Annual Increase = -396.92%

Minimum Annual ROE = -2079.86%

Quarterly (TTM)
Annual
YearROEChange
2024452.14%-396.92%
2023-152.28%-2.28%
2022-155.83%91.63%
2021-81.32%38.41%
2020-58.75%-97.18%
2019-2079.86%3.47%
2018-58.27%-50.42%
2017-117.54%133.20%
2016-50.40%-10.74%
2015-56.47%-6.07%

Verastem, Inc. (2VSA.F) Average ROE

How has 2VSA.F ROE performed in the past?

The current ROE of Verastem, Inc. (2VSA.F) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

48.01%

5-year avg

0.79%

10-year avg

-235.86%

Verastem, Inc. (2VSA.F) ROE vs. Peers

How is 2VSA.F’s ROE compared to its peers?

Verastem, Inc.’s ROE is less than Formycon AG (-39.02%), less than Zura Bio Limited (-51.70%), less than Heidelberg Pharma AG (-84.55%), less than 4basebio PLC (-63.53%), less than Medios AG (3.66%), less than Stratec SE (6.23%), greater than BRAIN Biotech AG (-133.24%), less than Newron Pharmaceuticals S.p.A. (1.67%), less than M1 Kliniken AG (15.83%), less than CureVac N.V. (29.18%),

CompanyROEMarket cap
-39.02%$440.73M
-51.70%$214.57M
-84.55%$132.40M
-63.53%$123.10M
3.66%$369.32M
6.23%$278.37M
-133.24%$66.20M
1.67%$387.64M
15.83%$338.76M
29.18%$986.71M

Build a custom stock screener for Verastem, Inc. (2VSA.F) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verastem, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Verastem, Inc. (2VSA.F) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Verastem, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Verastem, Inc.'s ROE?

How is the ROE calculated for Verastem, Inc. (2VSA.F)?

What is the highest ROE for Verastem, Inc. (2VSA.F)?

What is the 3-year average ROE for Verastem, Inc. (2VSA.F)?

What is the 5-year average ROE for Verastem, Inc. (2VSA.F)?

How does the current ROE for Verastem, Inc. (2VSA.F) compare to its historical average?